Zhenqing Feng

A novel human Fab antibody for Trop2 inhibits breast cancer growth <i>in vitro</i> and <i>in vivo</i>

Hong Lin, Huiling Zhang, Jun Wang et al. · International Journal of Cancer · 2013 · 90 citations · Full text

Medicine, Oncology, Pharmacology +14

A Human Fab-Based Immunoconjugate Specific for the LMP1 Extracellular Domain Inhibits Nasopharyngeal Carcinoma Growth <i>In Vitro</i> and <i>In Vivo</i>

Renjie Chen, Dawei Zhang, Yuan Mao et al. · Molecular Cancer Therapeutics · 2011 · 43 citations · Full text

Medicine, Oncology, Pharmacology +14

High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma

Genxiong Tang, Qi Tang, Lizhou Jia et al. · Pathology - Research and Practice · 2018 · 39 citations · Full text

Medicine, Oncology, Oral Pathology +17

BRD4 degrader ARV-825 produces long-lasting loss of BRD4 protein and exhibits potent efficacy against cholangiocarcinoma cells.

Qin Lu, Xiwei Ding, Tianlu Huang et al. · PubMed · 2019 · 35 citations · Full text

Medicine, Oncology, Pharmacology +16

Multiple therapeutic and preventive effects of 3,39-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia

Weiben William, Zhenqing Feng, A Steven · Journal of Biomedical Research · 2014 · 31 citations · Full text

Medicine, Nutritional Sciences, Oncology +11